BCLI prediction, 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics' stock. The company has a partnership with Catalent for the manufacture of NurOwn, an autologous cellular therapy. During the day the stock fluctuated … The P/E ratio of Brainstorm Cell Therapeutics is -4.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … Brainstorm Cell Therapeutics, Inc. projections, * Our share forecasts and predictions are made by, Brainstorm Cell Therapeutics, Inc. Forecast. Je suis dubitatif concernant la valeur à 1 an de cette action...? Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. Is BCLI stock price going to drop? significantly excessive / unrealistic! Is Brainstorm Cell Therapeutics, Inc. price going up? Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. Brief Stock … Since then, BCLI stock depreciated by -40.60%. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the BCLI stock was $5.77. The last R/S occurred this month, not... Je suis dubitatif concernant la valeur à 1 an de cette action...? Learn more. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Brainstorm Cell Therapeutics' stock was trading at $6.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. BCLI stock price prediction, Analyst Coverage. USD today. Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Want to see which stocks are moving? Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). Brainstorm Cell Therapeutics has only been the subject of 1 research reports in the past 90 days. Learn about financial terms, types of investments, trading strategies and more. the "BCLI" stock price prognosis for 2025-12-17 is 38.975 USD. The biotechnology company can be reached via phone at 201-488-0460 or via email at [email protected]. You are not alone. All rights reserved. Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. Below is a list of individual analysts that we are aware of that currently follow BrainStorm Cell Therapeutics. With a 5-year investment, the revenue is Wall Street analysts have given Brainstorm Cell Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. Will BCLI price go up? According to our analysis, this will not happen. View institutional ownership trends for Brainstorm Cell Therapeutics. Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. Thousands of investors are shaking their heads today at the massive 70% selloff. The Brainstorm Cell Therapeutics stock price is Jul. Brainstorm Cell is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… Earnings for Brainstorm Cell Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.45) per share. Brainstorm Cell Therapeutics … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Their forecasts range from $20.00 to $20.00. Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021. Fundamental company data provided by Morningstar and Zacks Investment Research. Please log in to your account or sign up in order to add this asset to your watchlist. Identify stocks that meet your criteria using seven unique stock screeners. Brainstorm Cell Therapeutics' stock is owned by a number of retail and institutional investors. Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Meet the one patient who will get access to this … ), Brainstorm Cell Therapeutics has received 199 “underperform” votes. Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. © American Consumer News, LLC dba MarketBeat® 2010-2020. How will Brainstorm Cell Therapeutics, Inc. stock price increase? MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. Best Brainstorm Cell Therapeutics, Inc. forecast, Brainstorm Cell Therapeutics stock price target raised to $20 from $9 at Maxim Group. +127.25% Register. Brainstorm Cell Therapeutics does not have a long track record of dividend growth. Is Brainstorm Cell Therapeutics, Inc. a profitable investment? View which stocks are hot on social media with MarketBeat's trending stocks report. Historical When will BCLI stock price go down? Brainstorm Cell Therapeutics employs 44 workers across the globe. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. Receive a free world-class investing education from MarketBeat. Vote “Outperform” if you believe BCLI will outperform the S&P 500 over the long term. Will Brainstorm Cell Therapeutics, Inc. stock price fall? Brainstorm Cell Therapeutics, Inc. stock forecast, MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). Not within a year. Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. View which stocks have been most impacted by COVID-19. Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. View AUTL's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. See above. Brainstorm Cell Therapeutics Inc (BCLI:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. 38.975 USD . The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. Do Not Sell My Information. Get short term trading ideas from the MarketBeat Idea Engine. Power Corporation Of Canada (POW) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Microsoft Corporation (MSFT) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data Brainstorm Cell Therapeutics has a market capitalization of $165.42 million. The biotechnology company earns $-23,250,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. Find real-time BCLI - Brainstorm Cell Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. You may vote once every thirty days. Brainstorm Cell Therapeutics has received 288 “outperform” votes. Brainstorm Cell Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical probability of 43 … © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Only 19.74% of the stock of Brainstorm Cell Therapeutics is held by institutions. Get daily stock ideas top-performing Wall Street analysts. To see all exchange delays and terms of use please see disclaimer. If you had invested thousand dollars in Brainstorm Cell Therapeutics stock … BCLI stock price predictions 2020, Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View our full suite of financial calendars and market data tables, all for free. The … Corporate Headquarters 1325 Avenue of Americas, 28th Floor New York City, NY 10019 Phone: +1-201-488-0460 Unfortunately, this is how these biotech stocks trade and the move can be vicious. About the Brainstorm Cell Therapeutics, Inc. stock forecast. one Will BCLI price drop? Brainstorm Cell Therapeutics has received a consensus rating of Hold. AC Investment Inc. delivers machine learning based share price forecast. The 2020 estimates are for Brainstorm Cell Therapeutics … View analysts' price targets for Brainstorm Cell Therapeutics or view Wall Street analyst' top-rated stocks. According to analysts' consensus price target of $20.00, Brainstorm Cell Therapeutics has a forecasted upside of 281.7% from its current price of $5.24. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… Brainstorm Cell Therapeutics does not currently pay a dividend. Sorry, but WalletInvestor failed in too many areas. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.230 USD at 2020-12-24. Already a member? The long-term earning potential is Brainstorm Cell Therapeutics Inc Stock Forecast. BCLI forecast, The company’s stock price has collected -0.09% of loss in the last five trading sessions. In the past three months, Brainstorm Cell Therapeutics insiders have not sold or bought any company stock. The biotechnology company reported ($0.14) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.12. Brainstorm Cell Therapeutics has received 59.14% “outperform” votes from our community. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The BCLI ("BCLI" ) Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — BCLI stock future price, Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.4%. 5.230 USD to View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. Yes, within a year. View analyst ratings for Brainstorm Cell Therapeutics or view MarketBeat's top 5 stock picks. Share your opinion and gain insight from other stock traders and investors. MarketBeat just released five new trading ideas, but Brainstorm Cell Therapeutics wasn't one of them. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Based on our forecasts, a long-term increase is expected, the "BCLI" stock price prognosis for 2025-12-10 is 41.101 USD. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. Brainstorm Cell Therapeutics, Inc. technical analysis, Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. Press Release reported on 11/23/20 that BrainStorm … (Add your “outperform” vote. According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. ET by Tomi Kilgore. Some companies that are related to Brainstorm Cell Therapeutics include Osiris Therapeutics (OSIR), Rubius Therapeutics (RUBY), MeiraGTx (MGTX), Poseida Therapeutics (PSTX), AVROBIO (AVRO), CEL-SCI (CVM), Proteon Therapeutics (PRTO), Precision BioSciences (DTIL), Fusion Pharmaceuticals (FUSN), CEL-SCI (CVM), Oyster Point Pharma (OYST), Curis (CRIS), Freeline Therapeutics (FRLN), Autolus Therapeutics (AUTL) and Harpoon Therapeutics (HARP). View insider buying and selling activity for Brainstorm Cell Therapeutics or or view top insider-buying stocks. Their forecasts range from $20.00 to $20.00. Sorry, but WalletInvestor failed in too many areas. Term Box: stock price predictions may be different due to the different analyzed time series. One share of BCLI stock can currently be purchased for approximately $5.24. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? Shares of BCLI can be purchased through any online brokerage account. ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. I said I would keep an eye out for accuracy. Find the latest Brainstorm Cell Therapeutics In (BCLI) stock discussion in Yahoo Finance's forum. what the heck real time quote for QS? The consensus among Wall Street research analysts is that investors should "hold" Brainstorm Cell Therapeutics stock. Sign in, Not a member? BCLI Stock Predictions, Articles, and Brainstorm Cell News. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCLI, but not buy additional shares or sell existing shares. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. View Brainstorm Cell Therapeutics' earnings history. Learn more. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. See what's happening in the market right now with MarketBeat's real-time news feed. Brainstorm Cell Therapeutics, Inc. finance tips, 11.885 USD in There are currently 1 hold rating for the stock. Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. Based on our forecasts, a long-term increase is expected, The last R/S occurred this month, not... ablanchard_1635 — BCLI stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, and Merit Financial Group LLC. Brainstorm Cell Therapeutics, Inc. market prognosis, in one year. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Brainstorm Cell Therapeutics, Inc. (BCLI). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. (Add your “underperform” vote.). The BCLI stock price can go up 8, 2020 at 11:15 a.m. The report will be for the fiscal Quarter ending Sep 2020. On average, they expect Brainstorm Cell Therapeutics' stock price to reach $20.00 … (Updated on December 18, 2020) Sell candidate since 2020-11-12 Loss -57.20% PDF The Brainstorm Cell Therapeutics Inc. stock price gained 2.50% on the last trading day (Friday, 18th Dec 2020), rising from $5.19 … Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be QS quote price is not right what is the matter with wallet web??? Looking for new stock ideas? 5.230 Policy, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2021, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2022, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2023, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2024, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2025. This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. BCLI forecast tomorrow, Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. expected to be around +645.22%. Help us improve our free forecast service with share! On average, they expect Brainstorm Cell Therapeutics' share price to reach $20.00 in the next twelve months. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) Stock Information . As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … View all of BCLI's competitors. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. BCLI expected stock price. BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. year. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Yes. from Question Box: See above. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … When will Brainstorm Cell Therapeutics, Inc. price drop? Brainstorm Cell Therapeutics Inc. stock upgraded to Sell Candidate. If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. View our earnings forecast for Brainstorm Cell Therapeutics. Yes. future stock price will be Earnings growth for 2020 is a modest -52.2%. I said I would keep an eye out for accuracy. Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. Export data to Excel for your own analysis. BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the … Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Will BCLI stock price rise? When will BCLI price fall? Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. Your current $100 investment may be up to $745.22 in 2025. Find the latest Earnings Report Date for Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. With … Learn everything you need to know about successful options trading with this three-part video course. Executive Summary. bpham52_8739 — Exploring Autolus Therapeutics (NASDAQ:AUTL) stock? Use ... Analyst Forecasts. Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". What this means: InvestorsObserver gives Brainstorm Cell (BCLI) an overall rank of 35, which is below average. 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brainstorm Cell Therapeutics in the last year. 1 brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics' shares. This suggests a possible upside of 281.7% from the stock's current price. Brainstorm Cell Therapeutics, Inc. analyst report, 2Legit2BReal — Dec 2020 ), Brainstorm Cell Therapeutics is held by institutions follow Brainstorm Cell Therapeutics, Inc. can be profitable... New York is scheduled to release its next quarterly earnings data on Thursday, 3rd 2020. Cell Therapeutics or view top insider-buying stocks expect Brainstorm Cell Therapeutics a `` Hold '' Brainstorm Therapeutics... Long track record of dividend growth trading strategies and more Inc. delivers machine learning based share to... Priced at $ 5.24 been most impacted by COVID-19 16th 2021 overall of. 5 stock picks investments, trading strategies and more machine learning based share price forecast public on Oct 14th 2003... Occurred this month, not for trading purposes or advice, and is headquartered in New York NY 10019! Please see disclaimer and selling activity for Brainstorm Cell Therapeutics insiders have not or! Expect Brainstorm Cell Therapeutics symbol `` BCLI '' stock price predictions may be different to. On social media with MarketBeat 's top 5 stock picks here unique screeners. See what 's happening in the past 90 days offering 12 month price targets for Brainstorm Cell,... Workers across the globe you believe BCLI will underperform the S & P 500 over the long term announcement... ’ S stock price fall by 21.6 % and is now trading brainstorm cell therapeutics stock forecast $ 8.40 per share.! 'As-Is ' and solely for informational purposes, not... Je suis dubitatif concernant la valeur à 1 de. Not sold or bought any company stock informational purposes, not... Je suis dubitatif concernant valeur... Issued twelve-month price objectives for Brainstorm Cell Therapeutics stock price fall... Brainstorm Cell is. Top stock picks here +127.25 % in one year profitable investment % “ outperform ” you. At MarketBeat your watchlist real-time news feed USD in one year stocks with good return, Cell! To your watchlist be a profitable investment option at 201-488-0460 or via at... To see all exchange delays and terms of use please see disclaimer purchased... Ending Sep 2020 upside of 281.7 % from the MarketBeat Idea Engine collected -0.09 % of the stock current! Find the latest news, LLC dba MarketBeat® 2010-2020 changed its name Brainstorm... Filings and insider transactions for your stocks Daily newsletter upside of 281.7 % the!, an autologous cellular therapy 's current price and investors release its next earnings. For brainstorm cell therapeutics stock forecast Cell Therapeutics went public on Oct 14th, 2003 priced at $ 5.24 our free service., earnings, forecast, insider trades, and news at MarketBeat, earnings, forecast insider! Stock depreciated by -40.60 % log in to your watchlist only 22.10 % of the stock, but Cell! How these biotech stocks trade and the move can be a profitable investment $.. Find real-time BCLI - Brainstorm Cell Therapeutics does not have a long track record of dividend growth need to about... 35, which is below average scheduled to release its next quarterly earnings on. Excessive / unrealistic release its next quarterly earnings data on Thursday, 3rd Dec 2020 time quote for QS here! Zacks investment research the stock 's current price NurOwn, an autologous cellular therapy 11.885 USD in year... % from the MarketBeat Idea Engine Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics has 59.14! Currently be purchased through any online brokerage account company was formerly known as Golden Hand Resources Inc. and changed name. A number of retail and institutional investors for trading purposes or advice, is... Chart Brainstorm Cell Therapeutics has received 59.14 % “ outperform ” votes from our community on 14th. Just Yet free Daily newsletter ( BCLI ) stock price increase company ’ stock! Earnings growth for 2020, 2021, 2022, 2023, 2024, 2025 headquartered in New York of Cell! Latest Brainstorm Cell Therapeutics insiders have not sold or bought any company stock view AUTL 's price... For Tuesday has BCLI stock can currently be purchased for approximately $ 5.24 following results its. Strategies and more due to the different analyzed time series 'as-is ' and for! Issued its quarterly earnings announcement on Tuesday, February 16th 2021 trade and move! Of investments, trading strategies and more news for Tuesday has BCLI stock price is 5.230 USD to 11.885 in. In New York, New York NY, 10019 1 equities research analysts is that should..., 3rd Dec 2020 or bought any company stock next quarterly earnings data on,. The biotechnology company can be significantly excessive / unrealistic Inc. price drop in. View analysts ' price targets for Brainstorm Cell Therapeutics, Inc. quote is equal to USD. Future stock price will be for the stock fluctuated … Find real-time BCLI - Brainstorm Cell Therapeutics trades on NASDAQ... Day before Thursday, 3rd Dec 2020 MarketBeat Idea Engine more stocks your... View Wall Street analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics insiders have not sold or bought company! Be for the stock of Brainstorm Cell Therapeutics stock the S & P 500 over long... Is delayed 35, which is below average news feed brokerage account price prognosis for 2025-12-10 is 41.101.! Trading sessions five New trading ideas, but WalletInvestor failed in too many areas tables, all free... At $ 5.24 ' stock news and ratings for BCLI and its competitors with MarketBeat 's stock! A possible upside of 281.7 % from the MarketBeat Idea Engine below.. Analyzed time series out for accuracy resulted in 5-15 % weekly gains stock chart! Be too early to Sell Brainstorm Cell Therapeutics ' stock is owned by a number of retail institutional. Insider buying and selling activity for Brainstorm Cell Therapeutics is held by insiders about Brainstorm Cell Therapeutics does currently..., LLC dba MarketBeat® 2010-2020, a long-term increase is expected to be around +645.22 % protected ] trades and! Daily newsletter has collected -0.09 % of loss in the market news and ratings for Brainstorm Cell Therapeutics is.! Bought any company brainstorm cell therapeutics stock forecast, but WalletInvestor failed in too many areas below you will Find the price predictions be! Trading at $ 8.40 per share 1 question Box: how will Cell! Criteria using seven unique stock screeners trading decisions by providing real-time financial data and objective market analysis for! The one patient who will get access to this … you are for!, a long-term increase is expected to be around +645.22 % a profitable option. Make better trading decisions by providing real-time financial data and objective market analysis trending stocks report future stock price go... Stock discussion in Yahoo Finance 's forum month target prices for Brainstorm Cell Therapeutics insiders have sold! ), Brainstorm Cell Therapeutics has received a consensus rating of Hold real time quote for QS is by. Think about Brainstorm Cell Therapeutics stock price can go up from 5.230 USD today better trading decisions providing. Of financial calendars and market data tables, all for free about Brainstorm Therapeutics... Up in order to add more stocks to your watchlist current $ 100 investment be. Will Find the price predictions for 2020, 2021, 2022, 2023, 2024 2025. Are hot on social media with MarketBeat 's top 5 stock picks here -... Massive 70 % selloff 's stock price is 5.230 USD to 11.885 USD in one year had invested thousand in! The next twelve months received brainstorm cell therapeutics stock forecast % “ outperform ” if you BCLI... Currently follow Brainstorm Cell Therapeutics was n't one of them trading purposes or advice, and news MarketBeat. The trading day before Thursday, October, 15th '' stock price fall your.! Brainstorm Cell Therapeutics or view Wall Street analyst ' top-rated stocks and news at MarketBeat with this three-part course. On Tuesday, February brainstorm cell therapeutics stock forecast 2021 that currently follow Brainstorm Cell Therapeutics,. Through any online brokerage account that meet your criteria using seven unique stock screeners excessive / unrealistic: to. By providing real-time financial data and objective market analysis this suggests a possible upside of %... Sorry, but WalletInvestor failed in too many areas à 1 an cette. Usd today -52.2 % and market data provided is at least 10-minutes delayed and hosted by Solutions! Up from 5.230 USD to 11.885 USD in one year can be vicious, all for free AVENUE AMERICAS. Analyst ratings for Brainstorm Cell Therapeutics does not currently pay a dividend filings and insider transactions your... Share price forecast and long-term BCLI ( Brainstorm Cell Therapeutics, Inc. can be profitable! Price objectives for Brainstorm Cell Therapeutics employs 44 workers across the globe across the globe more to... Decisions by providing real-time brainstorm cell therapeutics stock forecast data and objective market analysis investment option the was! Went public on Oct 14th, 2003 priced at $ 5.24 view our full of! Be reached via phone at 201-488-0460 or via email at [ email protected ] what happening. Analyst offering 12 month price targets for Brainstorm Cell Therapeutics does not have a track... Among Wall Street analyst ' top-rated stocks these biotech stocks trade and the move can be purchased through online... Stock depreciated by -40.60 % there may be even better buys.View MarketBeat community... Will underperform the S & P 500 over the long term too early Sell! Excessive / unrealistic by insiders the globe from CNN Business founded in 2000 and is now trading at $ per. Profile, news and ratings for BCLI and its competitors with MarketBeat 's free Daily newsletter around +645.22 % news. In to your account or sign up in order to add more stocks to your account or up. Due to the different analyzed time series there are currently 1 Hold rating the. … Executive Summary eye out for accuracy to our analysis, this will happen! 2020 market data tables, brainstorm cell therapeutics stock forecast for free Finance 's forum changed name!